Leo Qian

Company: Entrada Therapeutics Inc.

Job title: Co-Founder & Vice President - Discovery Research

Seminars:

Endosomal Escape Vehicle (EEV)-Conjugated Phosphorodiamidate Morpholino Oligomer (PMO) Therapeutics for the Treatment of Duchenne Muscular Dystrophy 5:00 pm

Understanding endosomal escape vehicle platform – an enhance lipid nanoparticlemediated delivery of genomic medicines Considering the value proposition of using endosomal escape vehicle-oligonucleotides for Duchenne Analyzing preclinical data to support this novel approachRead more

day: Day One